Thomas Gad, See remarks at Y-mAbs Therapeutics, Inc. (YMAB), sold 4,000 shares at $28.26 ($113K) on 2021-09-30, disclosed to the SEC on 2021-10-04.
Open-market sale of $113k YMAB by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| YMAB | SELL | 2024-06-11 | $841K | — | Filing → |
| YMAB | SELL | 2024-05-23 | $396K | — | Filing → |
| YMAB | SELL | 2024-03-07 | $128K | — | Filing → |